Markets by TradingView

Browsing Tag

clinical trial

33 posts

From $1 to $8? Why Analyst Experts Are Bullish on Cardiol

Sometimes stock market performance doesn’t line up with the fundamentals of a…

Small Pharma, Big Gains: The Power of Clinical Trial Results

For smaller pharmaceutical companies, valuation can be greatly impacted by progression in…

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology

Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug…

Cardiol Execs and Board Members Increase Equity, Signal Confidence

Members of the Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) executive team…

Cardiol’s Favorable Phase 2 Results Set the Table for Advanced Clinical Trials

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) recently presented excellent results from…

Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the…

Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1…

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol Therapeutics Inc. (NASDAQ:…